NCT02231346View on ClinicalTrials.gov

Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Comparison to a Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

April 30, 2006

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Berodual® Respimat® - inhaler

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02231346 - Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Comparison to a Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter